MyFinsight
Home
About
Contact
mck: the income statement
Download
Download image
Material Reconciling
Items
$302M
Medical Surgical
Solutions...
$2,947M
Operating
Segments-Prescription Technology...
$1,376M
Oncology And
Multispecialty...
$12,044M
North American
Pharmaceutical...
$86,481M
Revenues
$103,150M
(10.14%↑ Y/Y)
Gross profit
$3,542M
(9.05%↑ Y/Y)
Cost of sales
$99,608M
(10.18%↑ Y/Y)
Other income, net
$62M
(82.35%↑ Y/Y)
Operating income
$1,407M
(143.43%↑ Y/Y)
Total operating
expenses
$2,135M
(-20.04%↓ Y/Y)
Claims and litigation
charges, net
$2M
(-50.00%↓ Y/Y)
Income before income
taxes
$1,395M
(161.24%↑ Y/Y)
Interest expense
$74M
(-5.13%↓ Y/Y)
Restructuring, impairment, and
related charges, net
$63M
(-63.16%↓ Y/Y)
Selling, distribution,
general, and...
$2,074M
(-17.14%↓ Y/Y)
Net income
$1,163M
(305.23%↑ Y/Y)
Income tax expense
$232M
(-6.07%↓ Y/Y)
Net income
attributable to mckesson...
$1,110M
(360.58%↑ Y/Y)
Net income
attributable to...
$53M
(15.22%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
mck_logo_blue-svg
MCKESSON CORP (MCK)
mck_logo_blue-svg
MCKESSON CORP (MCK)